Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Agencies II01:17

Healthcare Agencies II

862
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
862
Standards of Care II01:19

Standards of Care II

851
Nurses bear specific legal responsibilities under several federal statutes, including:
851
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

58
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
58
Standards of Care I01:22

Standards of Care I

879
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
879
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

41
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
41
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

45
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
45

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Federal and State Programs and Resources for Chronic Kidney Disease.

The Senior care pharmacist·2023
Same author

Infectious Disease: Historic Triumphs and Future Tragedy?

The Senior care pharmacist·2023
Same author

Artificial Intelligence: The Future Is Here.

The Senior care pharmacist·2023
Same author

The Continuing Crisis: Drug Shortages.

The Senior care pharmacist·2023
Same author

Government Programs Aimed to Stop Elder Abuse.

The Senior care pharmacist·2023
Same author

Chronic Care Management in Medicaid.

The Senior care pharmacist·2023

Related Experiment Video

Updated: Nov 1, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.9K

Pharmacist Provider-Status Legislation Returns.

Paul Baldwin1

  • 1Baldwin Health Policy Group LLC.

The Senior Care Pharmacist
|June 19, 2021
PubMed
Summary
This summary is machine-generated.

The proposed pharmacist provider status act could enable Medicare Part B reimbursement for pharmacists in medically underserved areas. This legislation aims to expand healthcare access by recognizing pharmacists

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K

Related Experiment Videos

Last Updated: Nov 1, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.9K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K

Area of Science:

  • Health Policy
  • Pharmacy Practice
  • Healthcare Access

Background:

  • The Pharmacy and Medically Underserved Areas Enhancement Act, also known as the pharmacist provider status act, has been introduced in Congress.
  • Current healthcare legislation may not fully recognize pharmacists' roles in serving medically underserved populations.
  • Access to healthcare services in medically underserved areas remains a significant challenge.

Purpose of the Study:

  • To analyze the potential impact of the pharmacist provider status act on healthcare delivery.
  • To evaluate the likelihood of the proposed legislation's passage.
  • To discuss the implications of Medicare Part B reimbursement for pharmacist-provided services.

Main Methods:

  • Review of the proposed Pharmacy and Medically Underserved Areas Enhancement Act.
  • Analysis of legislative context and historical precedents for provider status.
  • Discussion of potential economic and healthcare access outcomes.

Main Results:

  • The bill proposes reimbursement for Medicare Part B services provided by pharmacists within their scope of practice.
  • Reimbursement would be specifically for services rendered in designated medically underserved areas.
  • The likelihood of the bill's passage is debated, considering various political and economic factors.

Conclusions:

  • Passage of the pharmacist provider status act could enhance healthcare access in underserved regions.
  • The legislation has the potential to broaden the role of pharmacists within the Medicare Part B framework.
  • Further analysis is needed to fully understand the long-term effects on patient care and healthcare systems.